Skip to content

Trilogy 200

by Respironics Inc. 2 variants

Trilogy 200 (AU1032800B) is a portable electric ventilator (FDA Class II) made by Respironics Inc., cleared under FDA 510(k) K093416 on 29 Jan 2010 and listed in FDA GUDID since 14 Oct 2016 (UDI-DI 00606959038233), active as of 23 Oct 2026. 5 FDA recalls are linked to it.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

2 ongoing

This device is named in the recall

Documents

510(k) K093416

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00606959038233 UDI-DI Date14 Oct 2016ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK093416 Date29 Jan 2010DecidedStatusActive

Official records

From the FDA record

Device description
Trilogy200 Ventilator, Bluetooth, Australia
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Across registries

2 registries list this device

  • FDA 510(k) K093416 decided 29 Jan 2010 Active
  • FDA GUDID UDI-DI 00606959038233 listed 14 Oct 2016 Listed

Recalls

5 recalls · 2 ongoing · FDA

    • Ongoing Z-0883-2023 FDA Class I initiated 7 Dec 2022

    The replacement silicone sound abatement foam installed into some Trilogy 100 and Trilogy 200 devices may separate from the plastic backing to which it is attached. If this were to happen, the foam could potentially block air inlet, which could result in a reduction in delivered therapy volume or pressure and could cause the device to alarm.

    • Ongoing Z-1956-2021 FDA Class I initiated 14 Jun 2021

    The polyester-based polyurethane (PE-PUR) foam may degrade into particles which may enter the devices air pathway and be ingested or inhaled by the user, and the PE-PUR foam may off-gas certain chemicals.

    • Terminated Z-1065-2016 FDA Class II initiated 18 Jan 2016

    Software Issue

    • Terminated Z-1143-2014 FDA Class I initiated 11 Feb 2014

    Internal testing revealed a potentially defective component on the power management board that could affect the function of certain Trilogy Ventilators resulting in loss of therapy to patients.

    • Terminated Z-2024-2012 FDA Class I initiated 27 Apr 2012

    The specified Trilogy units are being recalled because of the potential for a faulty component in the power supply.

Timeline

7 dated events

  1. Cleared FDA 510(k) K093416
  2. Recall initiated FDA recalls Z-2024-2012
  3. Recall initiated FDA recalls Z-1143-2014
  4. Recall initiated FDA recalls Z-1065-2016
  5. Listed FDA GUDID 00606959038233
  6. Recall initiated FDA recalls Z-1956-2021
  7. Recall initiated FDA recalls Z-0883-2023

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Generic name
Portable electric ventilator
Model / Ref / Catalog
Trilogy 200 Ventilator, Bluetooth, Australia, AU1032800B
Primary DI / UDI-DI
00606959038233
510(k) Number
FDA product code
CBK, NOU, DQA
GMDN term
Portable electric ventilator
Device class
Class II
Regulation number
868.5895, 870.2700
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code CBK (VENTILATOR, CONTINUOUS, FACILITY USE).

Other devices from Respironics Inc.

See all devices from Respironics Inc. →

Properties

  • Prescription use
  • Serial number
Other properties (13, all answered No)